Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular Biology Reports|August 12, 2021
KMT2A-ARHGEF12, a therapy related fusion with poor prognosisNada Assaf, Raphael Liévin, Fatiha Merabet, et al.
Carcinogenesis|February 25, 2009
Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancerLuca Persano, Lidia Moserle, Giovanni Esposito, et al.
Haematologica|June 22, 2023
Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemiaMargarita Maurer-Granofszky, Stefan Kohrer, Susanna Fischer, et al.
Leukemia|April 26, 2023
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcomeMarius Külp, Patrizia Larghero, Julia Alten, et al.
Iscience|July 8, 2022
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemiaMarius Külp, Anna Lena Siemund, Patrizia Larghero, et al.
Journal of Pediatric Hematology/Oncology|December 30, 2021
KMT2A-MLLT1 and the Novel SEC16A-KMT2A in a Cryptic 3-Way Translocation t(9;11;19) Present in an Infant With Acute Lymphoblastic LeukemiaRoberto R C de Matos, Gerson M Ferreira, Claus Meyer, et al.
Cancer Genetics|May 25, 2021
Therapy-related acute myeloid leukemia with KMT2A-SNX9 gene fusion associated with a hyperdiploid karyotype after hemophagocytic lymphohistiocytosisIngrid Sardou-Cezar, Bruno A Lopes, Francianne Gomes Andrade, et al.
Scientific Reports|February 18, 2017
Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 controlMauro S Malnati, Elisabetta Ugolotti, Maria Cristina Monti, et al.
Pageof 2